Background: Cigarette smoke contains compounds similar to coal tar, an ancient
| INTRODUCTION
Eczema is a chronic relapsing inflammatory skin disease characterized by a disrupted epidermal barrier 1,2 with a lifetime prevalence ranging from 16% to 20% in the UK and US, 3, 4 which is further increased in the developing countries. 5 Characteristically, an earlyonset eczema often progresses to other allergic diseases, 6-9 a phenomenon known as atopic march. 8, 9 In addition to a low quality of life 4, 10 of the affected individual, it also poses an economic burden on the families due to high cost of treatment. 10, 11 The association of two early life environmental exposures, maternal gestational smoking and breastfeeding duration, respectively has been reported in the literature. [12] [13] [14] [15] [16] [17] [18] Cigarette smoke exposure during the in utero period, a critical time window of development, 19 influences several long-term health outcomes. 20 Cigarette smoke has a similar composition to coal tar, 21 which is an ancient remedy of eczema. 22 Experimental studies suggest that coal tar may improve the skin barrier by inducing the AHR (aryl-hydrocarbon receptor)
gene. 22 Interestingly, cigarette smoke also influences the methylation of AHRR (aryl-hydrocarbon receptor repressor) 23 indicating a possible link between biological pathways influenced by cigarette smoke and those related to eczema. Existing studies report a protective effect of maternal gestational smoking for eczema in offspring, 16, 18 null effects, 24 and increased risks. 3, 25 Regarding breastfeeding, several studies have explored its association with eczema in offspring and have reported contradictory find-
ings. Elbert et al demonstrated that non-exclusive breastfeeding is
associated with a weak increase in the risk of eczema (adjusted odds ratio 1.11, 95%CI: 1.01, 1.23). 26 Ito et al 12 showed that longer breastfeeding is associated with an increased risk of atopic dermatitis in offspring whereas Lee et al have reported null effects. 27 Turati et al described that early weaning is protective of eczema. 28 Our group showed that in children with filaggrin loss of function mutation, a longer duration of breastfeeding reduced the risk of eczema at ages 1-or-2 years. 29 Ramirez et al reported an increased risk of eczema at age 6 years associated with mixed mode of feeding (combination of direct feeding, pumping and feeding, and formula feeding) compared to direct feeding at the breast. 30 Systematic reviews by Kramer et al and Lodge et al have reported a lower risk of eczema linked to exclusive breastfeeding. 14, 15 Although the above studies revealed contradictory findings regarding the association of smoking during pregnancy and breastfeeding with eczema when investigated separately, no study has yet investigated whether the combined effect of the two factors contributes towards the risk of eczema. It is known that if mother smokes during pregnancy, compounds of tobacco smoke may be stored in breast fat tissue. 31 These coal tar like compounds may then be passed to offspring during breastfeeding. 32 Thus, we hypothesize that combined effect of exclusive breastfeeding duration and maternal smoking on eczema lowers the risk of eczema in the offspring.
To this end, we analyzed the interaction of duration of breastfeeding and maternal smoking during pregnancy on eczema from infancy to late adolescence (ages 1-or-2, 4, 10, and 18 years) in boys and girls using data from the Isle of Wight birth cohort.
| METHODS

| Isle of Wight birth cohort
Isle of Wight birth cohort is a longitudinal cohort, established on the Isle of Wight, UK to prospectively study the natural history of allergic conditions. From January 1989 to February 1990, 1536 children were born on the Isle of Wight (IOW), among which, 1456 motherchild pairs were enrolled into the cohort study after exclusion of perinatal deaths, adoptions, and refusals. Children were followed up at 1, 2, 4, 10, and 18 years of age ( Figure 1 ). This study represents a dynamic cohort since some children did not participate in some assessments but rejoined in the next.
The research ethics committee on the IOW (NRES Committee South Central -Hampshire B, UK) and in Memphis (University of Memphis Institutional Review Board, FWA00006815) approved the study and informed written parental consent was obtained for all participants at recruitment and subsequently at each follow-up. The IOW birth cohort has been described in detail elsewhere.
33-35
| Data collection
Information regarding eczema symptoms was acquired through detailed interviews and examinations at the follow-ups at 1, 2, 4, 10, and 18 years. A postal or telephone questionnaire was sent if a visit was not possible. 36 At ages 1 and 2 years, all children came for a clinical visit, whereas at ages 10 and 18 years 88% and 75% were seen at clinical visits, respectively. Information regarding how many were seen at clinical visits is not available in our records. Eczema was defined using the Hanifin and Rajka criteria using the information obtained via questionnaires. 37 We ascertained all major features (itching, typical morphology and distribution, chronic or chronically relapsing itchiness, and personal history of atopic dermatitis) and some minor features (early age of onset, anterior neck folds) as required by the Hanifin and Rajka criteria. 38, 39 Since the 1st year and 2nd year follow-up was conducted in a small time window, we combined them for analytical purposes. Mothers were asked at childbirth regarding "how many cigarettes were you smoking during pregnancy?" This information was used to construct a binary smoking during pregnancy variable with categories "Yes" (If the mothers reported ≥1 cigarettes) and "No" (If the mothers reported 0 number of cigarettes). Regarding breastfeeding, the mother was asked at the 1-and 2-year follow-up whether the child was breastfed and the total duration of breastfeeding (in weeks).
In addition, age of starting formula feeding (in weeks) was also ascertained. Duration of exclusive breastfeeding (weeks) was determined by comparing the total duration of breastfeeding with the age of initiating formula feeding or introduction of solid foods.
Socio-economic status, maternal and paternal eczema, FLG loss of function genetic variants, and gender were included as MUKHERJEE ET AL.
| 1689 confounders since they potentially associate with maternal smoking, breastfeeding duration, and eczema. Parental occupation was reported at birth, number of children in the index child's bedroom was collected at age 4 years, and family income was ascertained at age 10 years. These three variables were clustered to produce a family social status variable used in our analyses. 40 Gender and maternal and paternal eczema were determined at birth.
| Genotyping
DNA samples were extracted from 1150 cohort participants from blood or saliva and assessed using GoldenGate genotyping assays 
| Statistical analysis
We plotted the proportion of eczema ages 1-or-2, 4, 10, and 18 years against duration of exclusive breastfeeding categorized into none, 1-15 weeks and more than 15 weeks comparing those with and without maternal smoking to descriptively assess their interplay.
Since maternal gestational smoking itself may influence breastfeeding duration it is difficult to interpret their crude combined effect on eczema. To address this, we calculated residual breastfeeding with the following equation: residuals = actual duration of breastfeeding -estimated effect of breastfeeding due to smoking.
These residuals are not explained by maternal smoking, making the two variables independent of each other. However, the residual exclusive breastfeeding duration (Resid-BF-duration) is correlated with exclusive breastfeeding duration (Spearman correlation coefficient: 0.93, P-value: <0.0001) and was used throughout the analysis.
To investigate the suggestive non-linear trends from the plots, we used repeated measures of eczema at ages 1-or-2, 4, 10, and 18 years as outcome and assessed the interaction of polynomial functions (cubic B-spline and quadratic) of Resid-BF-duration and age of eczema assessment using Generalized Linear Mixed Model (GLMM), Generalized Estimating Equation (GEE), and General Additive Models (GAM). The analyses were stratified by maternal gestational smoking. Thereafter, to explore linear associations we estimated the risk of eczema associated with the combined effect of maternal gestational smoking and duration of breastfeeding. The risks were assessed using log-linear models with repeated measures using GEE. 42 The log link function was used in the model to obtain risk ratios for the interaction of residual duration of exclusive breastfeeding and maternal gestational smoking. 43 Loss of function filaggrin genetic polymorphisms, gender, socio-economic status of offspring at age 10, maternal and paternal eczema status, and gestational age were included in the model as potential confounders. We started with a model containing all main effects and the interaction effect of maternal gestational smoking and duration of exclusive breastfeeding on the risk of eczema at different ages. After evaluation of whether the interaction term was significant, we assessed confounding on the joint effect of duration of exclusive breastfeeding and maternal smoking, that is, risk ratio (RR) = exp (β 1 ×maternal smoking
Additionally, to further evaluate whether the effect of exclusive breastfeeding duration differs if the mother smokes during pregnancy vs. not, we performed an analysis stratified by maternal gestational smoking using model with repeated measures of eczema. A Pvalue ≤ 0.05 was used to indicate statistical significance. Statistical analyses were performed using the SAS statistical package (version 9.4; SAS Institute, Cary, NC, USA).
Next, for each of the three transition periods of ages 1-or-2 to 4 years, 4 to 10 years, and 10 to 18 years we defined persistence of eczema as having eczema at both time-points. Similarly, we defined incidence if a person was eczema-free in the first time-point but developed eczema in the second time-point, and remission as having eczema in the first time-point and becoming eczema-free at the second time-point. These criteria were used to classify participants into incidence, remission, persistence at all three transition periods. We classified participants without eczema across all time-points as eczema-free. With persistent eczema vs eczema-free as outcome, we estimated the risks associated with the combined effect of gestational smoking and exclusive breastfeeding duration with repeated F I G U R E 1 Description of whole cohort participants followed up at each age. *Analytical sample refers to the sample that was analyzed at each age with complete information for eczema, breastfeeding duration, maternal gestational smoking and all other covariates measurements over the three transitions. Similarly, we estimated the risk with incident eczema vs eczema-free, and remitting vs eczema-free as outcome across all the transition periods.
| RESULTS
The number of participants enrolled and followed up at each age is demonstrated in Figure 1 . There was no significant difference in the prevalence of eczema (Tables 1), duration of exclusive breastfeeding, maternal smoking during pregnancy, FLG loss of function variants, gender, socio-economic status, and maternal and paternal eczema status between the total cohort with offspring eczema information and the sample analyzed at each of the ages 1-2, 4, 10, and 18 years (Table 2) .
We compared the prevalence of offspring eczema at ages 1-or-2, 4, 10, and 18 years between those with maternal gestational smoke exposure and those without ( Figure 2) . We have used three
Comparison of prevalence of eczema at ages 1-2 years, 4 years, 10 years, and 18 years between whole cohort and sample analyzed a . In addition, number of participants analyzed with incident, persistent, remitting eczema in the three transitions b of ages 1-or-2 to 4, ages 4 to 10, and ages 10 to 18 are also presented Only participants with no missing eczema information at both time points are considered. For example, in the total cohort, 1153 participants had eczema information at both ages 4 and 10 years. similarly, in the analyzed sample, 888 had eczema information at both 4 and 10 years.
categories It is known that the effect of maternal gestational smoking on the offspring may extend to the first year of life or even longer. 20 We performed an additional analysis by comparing children without any smoke exposure to children who were exposed to smoke in utero or passively within 1-or-2 years after childbirth (year in which the mother breastfed). We also found a significant protective effect on eczema with increasing Resid-BF-duration if the child was exposed to cigarette smoke in utero or during ages 1-or-2 years (Table S1 ).
Next, we considered three transition periods: 1-or-2 to 4 years, 4-10 years, and 10-18 years and assessed the interaction of Resid-BF-duration and maternal gestational smoking on persistent eczema vs eczema-free, incidence eczema vs eczema-free, and remission vs eczema-free as outcome using repeated measurements across all the transition periods. Results show that the risk of persistent eczema is lower with increasing Resid-BF-duration if the mother smoked during pregnancy ( 
| DISCUSSION
In this longitudinal and prospective birth cohort study, we explored risks of eczema associated with the interaction of duration of exclusive breastfeeding and maternal gestational smoking using repeated eczema measurements at 1-or-2, 4, 10, and 18 years. To make the two interacting variables independent of each other throughout the analyses, we used residual exclusive breastfeeding duration (Resid-BF-duration) calculated by regressing exclusive breastfeeding duration on maternal smoking. We found that if the mother smoked during pregnancy, a longer exclusive breastfeeding duration is protective of eczema in offspring (P-value: 0.04, Table 3 ). The combined effect of longer Resid-BF-duration and higher number of cigarettes smoked was also significantly associated with a lower risk of eczema with longer duration of breastfeeding. Stratification by maternal or paternal eczema did not change these associations suggesting no effect modification by parental eczema. Excluding four participants with very long duration of breastfeeding (≥60 weeks) also did not change the results. In agreement with this, the stratified analysis by maternal gestational smoking showed that longer Resid-BF-duration was protective of eczema only in the strata where mothers smoked during pregnancy (Table 4) . We additionally performed the analyses without taking into account the shared smoking-breastfeeding effect using the crude breastfeeding duration, which demonstrates similar results (Tables S2-S4 ).
Regarding persistent eczema determined from ages 1-or-2 to 4 years, ages 4 to 10 years, and ages 10 to 18 years, the interaction of maternal smoking during pregnancy and Resid-BF-duration also showed a significant protective effect (Table 3 ).
There was no significant difference in the study characteristics of the whole cohort and the study participants at ages 1-or-2, 4, 10, and 18 years indicating that a selection bias is unlikely. The diagnosis of eczema was made using the questionnaire based on Hanifin and
Rajka's criteria. 44 The chances of misclassification are low since the participants developed rashes in typical locations (anticubital or popliteal fossae, ankles, face or neck) validating the eczema definition. 44 All questionnaires focused on eczema in the preceding 12 months to minimize the potential for recall bias that might occur if participants were asked to recall the entire period between assessments.
One of the limitations of this study is that maternal smoking status is self-reported. However, we have assessed the DNA Breastfeeding duration was determined retrospectively from the mothers at ages 1-year and 2-year follow-up. It is unlikely to be affected by recall, since it has been shown that maternal recall within ≤3 years provides a valid and reliable estimate of breastfeeding history. 46 However, self-reported breastfeeding duration may be influenced by digit preference of the participants to report number of weeks close to a month (eg, 4 or 8 weeks). We avoided this by focusing on for instance 3, 9, 15 and 21 weeks of breastfeeding duration (Table 3 , Figure 3 ).
Experimental studies indicate that breast milk contains proteins 47 and fatty acids 48 that may influence the immune response affecting eczema. Other studies propose that cigarette smoke exposure also changes the T lymphocyte system. 49 Interestingly, tobacco smoke contains compounds such as polycyclic aromatic hydrocarbons (PAHs) similar to coal tar, 21 an ancient topical remedy of eczema. Nevertheless, smoking during pregnancy is not recommended because the health hazards related to smoking are far greater than the suggestive benefit from our findings. However, mothers should be encouraged to exclusively breastfeed for the longest possible duration even they did not quit smoking during pregnancy. Most importantly, future studies should explore the composition of breastmilk of mothers who smoked during gestation and determine the underlying genetic, molecular, and epigenetic pathways so that alternative targeted therapy can be developed to prevent or alleviate eczema.
